Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen

被引：0
|
作者：
Shinmi, Daisuke [1 ]
Masuda, Kazuhiro [2 ]
机构：
[1] Kyowa Hakko Kirin Co Ltd, Antibody & Biol Res Labo, Tokyo, Japan
[2] Kyowa Hakko Kirin Co Ltd, Oncol Res Labo, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-1101
引用
收藏
页码：332 / 332
页数：1
相关论文
共 50 条
  • [1] Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen
    Shinmi, Daisuke
    Nakano, Ryosuke
    Mitamura, Keisuke
    Suzuki-Imaizumi, Minami
    Iwano, Junko
    Isoda, Yuya
    Enokizono, Junichi
    Shiraishi, Yasuhisa
    Arakawa, Emi
    Tomizuka, Kazuma
    Masuda, Kazuhiro
    CANCER MEDICINE, 2017, 6 (04): : 798 - 808
  • [2] Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen
    Sedlik, Christine
    Heitzmann, Adele
    Viel, Sophie
    Sarkouh, Rafik Ait
    Batisse, Cornelie
    Schmidt, Frederic
    De la Rochere, Philippe
    Amzallag, Nathalie
    Osinaga, Eduardo
    Oppezzo, Pablo
    Pritsch, Otto
    Sastre-Garau, Xavier
    Hubert, Pascale
    Amigorena, Sebastian
    Piaggio, Eliane
    ONCOIMMUNOLOGY, 2016, 5 (07):
  • [3] A novel dual drug antibody-drug conjugate targeting hTrop2 has synergetic antitumor activity in solid tumor models
    Zhu, Jie
    Zhao, Xiaobei
    Li, Eileen
    Xu, Hong
    Nie, Lei
    Chen, Gang
    Wang, Haibing
    CANCER RESEARCH, 2024, 84 (06)
  • [4] Targeting a Radiosensitizing Antibody-Drug Conjugate to a Radiation-Inducible Antigen
    Lewis, Calvin D.
    Singh, Abhay K.
    Hsu, Fong-Fu
    Thotala, Dinesh
    Hallahan, Dennis E.
    Kapoor, Vaishali
    CLINICAL CANCER RESEARCH, 2021, 27 (11) : 3224 - 3233
  • [5] Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicity
    Christianson, Helena C.
    Menard, Julien A.
    Chandran, Vineesh Indira
    Bourseau-Guilmain, Erika
    Shevela, Dmitry
    Lidfeldt, Jon
    Mansson, Ann-Sofie
    Pastorekova, Silvia
    Messinger, Johannes
    Belting, Mattias
    ONCOTARGET, 2017, 8 (40) : 66960 - 66974
  • [6] Antibody-drug conjugate directed against the guanylyl cyclase antigen for the treatment of gastrointestinal malignancies
    Almhanna, Khaldoun
    Prithviraj, Gopi K.
    Veiby, Petter
    Kalebic, Thea
    PHARMACOLOGY & THERAPEUTICS, 2017, 170 : 8 - 13
  • [7] Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody-Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines
    Anzai, Takahiro
    Saijou, Shinji
    Takashima, Hiroki
    Hara, Misato
    Hanaoka, Shingo
    Matsumura, Yasuhiro
    Yasunaga, Masahiro
    PHARMACEUTICALS, 2022, 15 (07)
  • [8] Development of a novel antibody-drug conjugate targeting endosialin/TEM-1: potent antitumor activity in sarcoma
    Sala, Gianluca
    Iacobelli, Stefano
    Capone, Emily
    PIccolo, Enza
    Sauniere, Jean-Fred
    Douet, Vanessa Vannucci
    CANCER RESEARCH, 2017, 77
  • [9] Novel targets for antibody-drug conjugate therapy
    Grandi, A. G.
    Campagnoli, S. C.
    Parri, M. P.
    De Camilli, E. D. C.
    Jin, B. J.
    Sarmientos, P. S.
    Grandi, G. G.
    Terracciano, L. T.
    Pileri, P. P.
    Viale, G. V.
    Grifantini, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 41 - 41
  • [10] NOVEL DOXORUBICIN-MONOCLONAL ANTICARCINOEMBRYONIC ANTIGEN-ANTIBODY IMMUNOCONJUGATE ACTIVITY IN-VITRO
    LAU, A
    BERUBE, G
    FORD, CHJ
    GALLANT, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (10) : 1305 - 1312
12345